India’s IPO market revives this week with three new issues worth over Rs 1,750 crore — Orkla India, Game Changers Texfab, and Jayesh Logistics — signaling renewed investor enthusiasm amid record-high markets.

Docon Technologies has divested a 10% stake in Thyrocare Technologies for a substantial Rs 667 crore, bringing its ownership down to 61%. Notable mutual funds like ICICI Prudential MF and HDFC MF came together to acquire a hefty chunk of the shares sold.

In a three-day trading week, Nifty gained 0.33%, attempting a breakout from a multi-month consolidation. With improving technical momentum and strong moving averages, sustaining above 25,900 could confirm a new bullish trend.

Markets extended their winning streak for the fourth week, with Nifty up 0.33% and Sensex 0.31%. Optimism from strong earnings and trade hopes drove sentiment, though profit-booking and cooling indicators signal near-term caution.

Agro-chemical firm Bharat Rasayan s board has greenlit a 1:1 bonus share issue and a 1:2 stock split, aiming to enhance share liquidity and broaden its investor base. This move will see existing Rs 10 shares divided into two Rs 5 shares, followed by a bonus issuance. The company reported a robust Rs 140.92 crore net profit for FY25.

Veteran investor Vijay Kedia’s portfolio, valued at around Rs 1,320 crore across 16 stocks in Q2 FY26, saw strong gains with Repro India, Neuland Labs, and Elecon Engineering leading, while Affordable Robotic lagged sharply.

Zen Technologies reported a 28% fall in Q2 FY26 revenue to Rs 173.5 crore, while net profit dipped 2.2% to Rs 62 crore. H1FY26 shows a 30% revenue decline and 20% lower profit.

Venkatesh Balasubramaniam highlights expensive Indian markets with muted EPS growth, cautious sector bets, and selective opportunities in autos, hospitality, mid-cap IT, and energy amid rising oil prices and IPO exuberance.

GST rate cuts have boosted Indian auto demand, particularly entry-level vehicles and two-wheelers, while festive momentum, exports, and improved OEM fundamentals support cautious investor optimism amid temporary incentives.